Merck & Co., Inc.

MRK
Healthcare
$133.72
2.54%Overvalued

Merck & Co., Inc. (MRK) is a Healthcare company that currently yields 2.54% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $84.76 and the overvaluation threshold at $126.90. Merck & Co., Inc. holds a quality score of 45/100 (Average), reflecting 14 consecutive years of dividend growth. The 5-year dividend CAGR stands at 6.7%.

MRK Dividend Yield History — Weiss Valuation

Underval. $84.76Overval. $126.90

Distance to undervalued

Entry price is stretched

Needs 36.6% downside to reach the Weiss buy zone

Undervaluation starts near $84.76, where the annual dividend would imply roughly 4.01% yield. That is 1.47% above today's yield.

Buy-zone price

$84.76

Target yield

4.01%

Research checklist

What to clear before buying the yield

Updated Nov 21, 2026

Dividend durability

14Y

Long dividend history supports a deeper look.

Earnings payout

343%

Coverage deserves a closer look in filings.

Cash payout

62%

Free cash flow coverage supports the payment.

Dividend growth

6.7%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-11-20 → 2026-11-21

Price

-1.8%

$136.15 → $133.72

Price fell 1.8% since the prior snapshot.

Why Now?

Merck & Co., Inc. is trading near its historical overvaluation band.

Current yield 2.5% vs historical max 5.8% (44% of maximum).

14 consecutive years without a dividend cut.

Elevated payout ratio of 343%.

What matters now

Read the signal before the headline yield

Valuation is the brake here: the yield is compressed versus its own history.

The 45/100 quality score says the headline yield needs extra skepticism.

The earnings payout ratio is above 100%, so coverage is the first risk to unpack.

MRK Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$271

Year 10 Income

$667

Yield on Cost

6.99%

Total Income

$4,372

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what MRK dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

MRK Dividend Quality Score

Quality Score

45/ 100

Average

Payout Ratio0/25
Dividend Streak20/25
Growth (CAGR 5Y)15/20
Yield vs History0/15
FCF Coverage10/15

Key Metrics

Current Price$133.72
Annual Dividend$3.40
Current Yield2.54%
Yield — Max (10Y)5.79%
Yield — Min (10Y)2.79%
Undervalued Below$84.76
Overvalued Above$126.90
Payout Ratio343.43%
CAGR Dividend 5Y6.7%
CAGR Dividend 10Y6.6%
Years No Cut14y

Invest in MRK

Check Merck & Co., Inc. availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

14
consecutive years of dividend growth